SNDX financials
Syndax Pharmaceuticals (SNDX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
SNDX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $172.35M | $165.38M | -$273.08M | -$285.42M | -3.29 |
| 2024 | $23.68M | $22.85M | -$339.67M | -$318.76M | -3.73 |
| 2023 | $0.00 | $0.00 | -$229.95M | -$209.36M | -2.98 |
| 2022 | $0.00 | $0.00 | -$151.76M | -$149.34M | -2.46 |
| 2021 | $139.71M | $139.71M | $26.22M | $24.93M | 0.48 |
| 2020 | $1.52M | $1.52M | -$71.42M | -$73.07M | -1.77 |
- SNDX revenue was $172.35M in fiscal 2025, net income -$285.42M.
Updated 2026-11-02 23:14 UTC